Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials
Authors:
- Peter Samuel EidPEPeter Samuel Eid
- Doaa Alaa IbrahimDIDoaa Alaa Ibrahim
- Ahmad Helmy ZayanAZAhmad Helmy Zayan
- Manal Mahmoud Abd ElrahmanMEManal Mahmoud Abd Elrahman
- Mostafa Ahmed Abdo ShehataMSMostafa Ahmed Abdo Shehata
- Hend KandilHKHend Kandil
- Mahmoud Ahmed AbouibrahimMAMahmoud Ahmed Abouibrahim
- Luc Minh DuyLDLuc Minh Duy
- Ashraf ShinkarASAshraf Shinkar
- Muhammed Khaled ElfaituriMEMuhammed Khaled Elfaituri
- Le Huu Nhat MinhLe Huu Nhat Minh
- Mostafa Mahmoud FahmyMFMostafa Mahmoud Fahmy
- 11 August 2020
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 26 (1) , 127-136
Abstract
Diuretics have an essential role in the management of heart failure (HF). However, each drug has its own benefit and side effect. Side effects include fluid, electrolyte abnormalities, and acid-base disturbance. These adverse effects of diuretics predispose patients to serious cardiac arrhythmias and may increase the risk of arrhythmic mortality. Herein, we aim to summarize the relative efficacy and safety of all available diuretics used in the treatment of patients with HF. In June 2017, a systematic electronic database search was conducted in nine databases. All randomized controlled trials (RCTs) comparing the different diuretics used in HF were included for meta-analysis. The protocol was registered in Prospero with CRD42018084819. Among the included 54 studies (10,740 patients), 34 RCTs were eligible for quantitative network meta-analysis (NMA) and traditional meta-analysis while the other 20 studies were qualitatively analyzed. Our results showed that azosemide and torasemide caused a significant reduction in brain natriuretic peptide (BNP) level. Torasemide also caused a significant decrease in collagen volume fraction (CVF) and edema. No significant difference between the agents concerning glomerular filtration rate (GFR), water extraction, and sodium excretion was demonstrated. Regarding side effects, no significant difference among diuretics was observed in terms of hospital readmission and mortality rates. Diuretics are the main treatment of hypervolemia in HF patients. The choice of appropriate diuretic is essential for successful management and is mainly guided by patient clinical situations and the presence of other co-morbidities.Keywords
This publication has 49 references indexed in Scilit:
- The pathophysiology of heart failureCardiovascular Pathology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Effects of Prolonged-Release Torasemide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded–End Point, Active-Controlled StudyClinical Therapeutics, 2011
- Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart FailureHypertension, 2009
- Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failureHeart, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Urinary electrolyte excretion after frusemide, amiloride and a combination of these drugs: an open, crossover studyCurrent Medical Research and Opinion, 1984
- Clinical Trial of Bumetanide Versus Furosemide in Patients with Congestive Heart FailureThe Journal of Clinical Pharmacology, 1981
- Evaluation of a New Diuretic, Diapamide, in Congestive Heart FailureThe Journal of Clinical Pharmacology, 1979
- A COMPARISON OF THE DIURETIC ACTION OF MERCAPTOMERIN, ETHACRYNIC ACID AND FUROSEMIDE IN CONGESTIVE HEART FAILUREActa Medica Scandinavica, 1970